Skip to main content
Premium Trial:

Request an Annual Quote

Cannabis Sciences Startup Dewey Scientific Raises $1.3M

NEW YORK — Cannabis sciences firm Dewey Scientific said today that it has raised roughly $1.3 million in seed funding in a round led by undisclosed private investors.

The Pullman, Washington-based company was founded last year by Washington State University scientists to offer molecular breeding and genomic services for cannabis cultivation.

"While more established crops have benefitted from genomics and advanced breeding methods, the prohibition of cannabis has created a gap in available technology," Dewey Scientific Cofounder Paul Mihalyov said in a statement. "We are providing industrial cannabis farmers with the same scientific resources that are available to Washington's other top agricultural commodities like wheat, hops, and apples."

Washington State legalized cannabis for medical use in 1998 and for recreational use in 2012.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.